Cabaletta Bio, Inc. (CABA) vs Mobia Medical, Inc. Common Stock (MOBI)

A side-by-side comparison of Cabaletta Bio, Inc. and Mobia Medical, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CABA

Cabaletta Bio, Inc.

$329M

$2.02HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

MOBI

Mobia Medical, Inc. Common Stock

$293M

$8.80HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — CABA vs MOBI

growth of $100 · dividends reinvested · last 1y

CABA -49.9% (-49.9%/yr)MOBI -36.1% (-36.1%/yr)MOBI compounded faster over this window

CABA MOBI

CABA vs MOBI: by the numbers

•CABA is the larger company ($329M vs $293M market cap).
•Both run net losses; CABA's is the smaller (0.00% vs -145.12% net margin).

Metrics side by side

Valuation

Metric	CABA	MOBI
P/B ratio	1.56	1.70

Profitability

Metric	CABA	MOBI
Gross margin	0.00%	81.07%
Operating margin	0.00%	-144.71%
Net margin	0.00%	-145.12%
ROE	-86.10%	N/A
ROIC	-85.56%	-122.21%

Growth (annualized)

Metric	CABA	MOBI
Total return CAGR (5Y)	-28.71%	N/A

Go deeper

Full CABA analysis Full MOBI analysis Interactive comparison tool

Dig into the metrics

Cabaletta Bio ROE Mobia Medical, Inc. Common Stock ROE Cabaletta Bio operating margin Mobia Medical, Inc. Common Stock operating margin Cabaletta Bio revenue growth Mobia Medical, Inc. Common Stock revenue growth Cabaletta Bio free cash flow Mobia Medical, Inc. Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.